Decorin modulates matrix mineralization in vitro

Biochemical and Biophysical Research Communications

Volumn 305, Issue 1, 2003, Pages 6-9

  Mochida, Yoshiyuki ^a,b   Duarte, Wagner R ^a   Tanzawa, Hideki ^b   Paschalis, Eleftherios P ^c   Yamauchi, Mitsuo ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Collagen matrix mineralization; Decorin; Osteoblast

Indexed keywords

DECORIN;

ACCELERATION; ANIMAL CELL; ARTICLE; CELL CLONING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; IMMUNOPRECIPITATION; IN VITRO STUDY; MINERALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; WESTERN BLOTTING;

EID: 0038069212     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00693-4     Document Type: Article

References (17)

1. Vogel K.G., Paulsson M., Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 223:1984;587-597.
2. Weber I.T., Harrison R.W., Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J. Biol. Chem. 271:1996;31767-31770.
3. Scott J.E. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry. 35:1996;8795-8799.
4. Hoshi K., Kemmotsu S., Takeuchi Y., Amizuka N., Ozawa H. The primary calcification in bones follows removal of decorin and fusion of collagen fibrils. J. Bone Miner. Res. 14:1999;273-280.
5. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:1997;729-743.
6. Corsi A., Xu T., Chen X.D., Boyde A., Liang J., Mankani M., Sommer B., Iozzo R.V., Eichstetter I., Robey P.G., Bianco P., Young M.F. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17:2002;1180-1189.
7. Wang D., Christensen K., Chawla K., Xiao G., Krebsbach P.H., Franceschi R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J. Bone Miner. Res. 14:1999;893-903.
8. Fisher L.W., Stubbs III J.T., Young M.F. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. Suppl. 266:1995;61-65.
9. Santra M., Eichstetter I., Iozzo R.V. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J. Biol. Chem. 275:2000;35153-35161.
10. Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21:2000;393-411.
11. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:2002;17-29.
12. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96:1983;191-198.
13. Quarles L.D., Yohay D.A., Lever L.W., Caton R., Wenstrup R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J. Bone Miner. Res. 7:1992;683-692.
14. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology. 12:2002;107R-116R.
15. Chen C.C., Boskey A.L. Mechanisms of proteoglycan inhibition of hydroxyapatite growth. Calcif. Tissue Int. 37:1985;395-400.
16. Sugars R.V., Milan A.M., Brown J.O., Waddington R.J., Hall R.C., Embery G. Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Connect. Tissue Res. 44:2003;189-195.
17. Iozzo R.V. The biology of the small leucine-rich proteoglycans. J. Biol. Chem. 274:1999;18843-18846.